(Q37130144)

18 August 2017

1 reference

title

Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? (English)

1 reference

18 August 2017

0 references

N G Forouhi

3

0 references

author name string

N Sattar

series ordinal

1

1 reference

18 August 2017

S G Wannamethee

series ordinal

2

1 reference

18 August 2017

publication date

8 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

51

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

926-940

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-008-0954-7

18 August 2017

exact match

0 references

cites work

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-0954-7

Relation between iron stores and non-insulin dependent diabetes in men: case-control study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-0954-7

Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-0954-7

The diabetes risk score: a practical tool to predict type 2 diabetes risk

21 January 2018

1 reference

12 December 2020

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

1 reference

12 December 2020

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

1 reference

12 December 2020

Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study

1 reference

12 December 2020

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

1 reference

12 December 2020

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Adiponectin and protection against type 2 diabetes mellitus

1 reference

12 December 2020

C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

1 reference

12 December 2020

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

1 reference

12 December 2020

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

1 reference

12 December 2020

PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.

1 reference

12 December 2020

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

1 reference

12 December 2020

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

1 reference

12 December 2020

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

12 December 2020

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

1 reference

12 December 2020

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study

1 reference

12 December 2020

Inflammatory markers and risk of developing type 2 diabetes in women

1 reference

12 December 2020

Insulin resistance, inflammation, and the prediabetic state

1 reference

12 December 2020

Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.

1 reference

12 December 2020

Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy

1 reference

12 December 2020

Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes

1 reference

12 December 2020

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

12 December 2020

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis

1 reference

12 December 2020

C-reactive protein and its role in metabolic syndrome: mendelian randomisation study

1 reference

12 December 2020

An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes

1 reference

12 December 2020

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

1 reference

12 December 2020

Predicting the 20-year diabetes incidence rate.

1 reference

12 December 2020

Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort.

1 reference

12 December 2020

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

1 reference

12 December 2020

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

1 reference

12 December 2020

Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study

1 reference

12 December 2020

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

1 reference

12 December 2020

Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology

1 reference

12 December 2020

Inflammation and metabolic disorders

1 reference

12 December 2020

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

1 reference

12 December 2020

Overproduction of large VLDL particles is driven by increased liver fat content in man.

1 reference

12 December 2020

Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes

1 reference

12 December 2020

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

1 reference

12 December 2020

Multiple biomarkers for the prediction of first major cardiovascular events and death

1 reference

12 December 2020

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

1 reference

12 December 2020

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

1 reference

12 December 2020

A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

1 reference

12 December 2020

Role of adiponectin in the regulation of carbohydrate and lipid metabolism

1 reference

12 December 2020

Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study

1 reference

12 December 2020

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

1 reference

12 December 2020

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study

1 reference

12 December 2020

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

12 December 2020

Inflammation and insulin resistance

1 reference

12 December 2020

Body iron stores in relation to risk of type 2 diabetes in apparently healthy women

1 reference

12 December 2020

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

1 reference

12 December 2020

The role of IL-6 in mediating the anti-inflammatory effects of exercise.

1 reference

12 December 2020

Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study

1 reference

12 December 2020

Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.

1 reference

12 December 2020

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

12 December 2020

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

12 December 2020

Genetic variation, C-reactive protein levels, and incidence of diabetes.

1 reference

12 December 2020

Adiponectin and Coronary Heart Disease

1 reference

12 December 2020

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

1 reference

12 December 2020

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study

1 reference

12 December 2020

Insight into the nature of the CRP-coronary event association using Mendelian randomization.

1 reference

12 December 2020

Effect of the inflammatory response on trace element and vitamin status.

1 reference

12 December 2020

Adiponectin actions in the cardiovascular system

1 reference

12 December 2020

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

1 reference

12 December 2020

Leptin and incident type 2 diabetes: risk or protection?

1 reference

12 December 2020

High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA study

1 reference

12 December 2020

Adipokines and Risk of Type 2 Diabetes in Older Men

1 reference

12 December 2020

Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

1 reference

12 December 2020

Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis

1 reference

12 December 2020

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

1 reference

12 December 2020

Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

1 reference

12 December 2020

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

12 December 2020

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed

1 reference

12 December 2020

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

1 reference

12 December 2020

Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.

1 reference

12 December 2020

Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans

1 reference

12 December 2020

10.1007/S00125-008-0954-7

Identifiers

DOI

1 reference

18 August 2017

1 reference